A randomized trial of treatment for anterior cruciate ligament reconstruction by radial extracorporeal shock wave therapy.
OrthoEvidence Journal (OE Journal) - ACE Report
Epub Ahead of Print
BMC Musculoskelet Disord. 2024 01-Jan;():. 10.1186/s12891-024-07177-8What this means for my practice?
rESWT may accelerate early improvements in pain, knee function, and ROM following ACL reconstruction when combined with standard rehabilitation. These findings suggest rESWT may be a useful addition for improving early rehabilitation outcomes and facilitating recovery progression. Key limitations include lack of imaging-based healing outcomes and uncertainty regarding optimal treatment dosage and long-term effectiveness.
Study Summary
Sixty-three patients with anterior cruciate ligament (ACL) reconstruction were randomized to receive standard rehabilitation plus radial extracorporeal shock wave therapy (rESWT) or standard rehabilitation plus sham rESWT. The primary outcomes of interest were Lysholm Knee Score (LKS), range of motion (ROM), visual analogue scale (VAS), and International Knee Documentation Committee (IKDC) score. Outcomes were assessed at baseline and at 3, 6, and 24 weeks post-treatment. Overall, the results of the study revealed that rESWT significantly improved knee function, pain, and ROM at early follow-up (3 and 6 weeks) compared with rehabilitation alone, although no significant between-group differences were observed at 24 weeks. These findings suggest rESWT may accelerate early postoperative recovery following ACL reconstruction.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!
0 of 4 monthly FREE articles unlocked
